Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Abbott Labs | LSE:ABT | London | Ordinary Share | COM STK NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 53.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMABT
RNS Number : 4568F
Abbott Laboratories
27 July 2016
Notification to RNS
Company: Abbott Laboratories TIDM: ABT Headline: Abbott Laboratories Files Forms 4
Abbott Laboratories (the "Company")
27 July 2016
Abbott Laboratories Files Forms 4
The Company informs its shareholders that on 27 July, 2016, in accordance with Section 16(a) of the U.S. Securities Exchange Act of 1934, as amended, several Forms 4 (the report on Form 4 being a statement of changes in the beneficial ownership of its officers, directors and 10% owners) ("Form 4") were filed with the U.S. Securities and Exchange Commission ("SEC"). The Forms 4 can be found on the SEC website at http://www.sec.gov.
A copy of the Forms 4 have been submitted to the National Storage Mechanism on the date of this announcement and is, or will shortly be, available for inspection at http://www.morningstar.co.uk/uk/NSM.
Issued by: Abbott Laboratories
CONTACT: Financial: Scott Leinenweber, +1-224-668-0791, Michael Comilla, +1-224-668-1872, or Jeffrey Byrne, +1-224-668-8808, or Media: Scott Stoffel, +1-224-668-5201, Darcy Ross, +1-224-667-3655, or Elissa Maurer, +1-224-668-3309.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEAEXXADKKEAF
(END) Dow Jones Newswires
July 28, 2016 02:00 ET (06:00 GMT)
1 Year Abbott Labs Chart |
1 Month Abbott Labs Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions